News and Events
Find out all about our latest news and also what industry events we will be attending in the coming months via the links below.
Latest News

CARBOGEN AMCIS Announces Leadership Transition
BUBENDORF, Switzerland (February 3, 2025) — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has announced the departure of its current CEO, Pascal Villemagne as of March 31 and the appointment of his replacement, Stephan Fritschi.
03 February 2025

Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site
BUBENDORF, Switzerland (January 13, 2025) — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of a Swissmedic inspection of its Vionnaz facility, reaffirming the site’s compliance with high regulatory standards.
10 January 2025

CARBOGEN AMCIS Announces Two Successful FDA Inspections at Its Manufacturing Sites in Neuland and Aarau, Switzerland
BUBENDORF, Switzerland (July 22, 2024) —Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of U.S. Food and Drug Administration (FDA) inspections at its Neuland and Aarau sites.
24 July 2024

CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
BUBENDORF, Switzerland (19 March 2024) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai.
19 March 2024

CARBOGEN AMCIS Manchester wins prestigious Chemical Industry Award for world-class manufacturing performance
Manchester, UK (20 June 2023) – CARBOGEN AMCIS Manchester, a member of the Switzerland-based CARBOGEN AMCIS Group, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, won the Manufacturing and Resource Efficiency Award at the prestigious Chemistry Industry Awards last week.
20 June 2023

CARBOGEN AMCIS announces successful FDA and Swissmedic inspections of its facilities in Switzerland
BUBENDORF, Switzerland (02 June 2023) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the completion of a U.S. Food and Drug Administration (FDA) inspection at its headquarters in Bubendorf, Switzerland and a Swissmedic routine inspection at Bubendorf, Aarau and Neuland, Switzerland.
02 June 2023

CARBOGEN AMCIS opens new state-of-the-art facility dedicated to sterile liquid drug product manufacturing in France
Bubendorf, Switzerland (3 February 2023) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has opened a state-of-the-art facility in Saint-Beauzire, France.
03 February 2023

CARBOGEN AMCIS announces successful Swissmedic inspection at Vionnaz, Switzerland
29 September 2022

Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19
MEYLAN, France, BUBENDORF, Switzerland, (November 3rd, 2021) - NH TherAguix, a clinical stage company developing innovative nanomedicine for the treatment of cancer, and CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and Drug Products manufacturing company, announced today the release of a new batch of AGuIX Drug Product for clinical trials.
09 December 2021

NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS
MEYLAN, France, BUBENDORF, Switzerland, (November 3rd, 2021) - NH TherAguix, a clinical stage company developing innovative nanomedicine for the treatment of cancer, and CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and Drug Products manufacturing company, announced today the release of a new batch of AGuIX Drug Product for clinical trials.
03 November 2021
Upcoming Events
Clear
Search
- All
- 01/04/2025|01/04/2025
- 03/11/2025|05/11/2025
- 04/06/2025|05/06/2025
- 05/05/2025|06/05/2025
- 06/11/2024|06/11/2024
- 07/05/2025|09/05/2025
- 08/10/2025|10/10/2025
- 09/04/2025|11/04/2025
- 11/06/2025|12/06/2025
- 17/03/2025|20/03/2025
- 20/05/2025|22/05/2025
- 23/07/2025|27/07/2025
- 24/06/2025|26/06/2025
- 25/11/2025|26/11/2025
- 28/10/2025|30/10/2025

Absolvierenden-Messe Basel 2025
Basel Messe, Switzerland
Booth #2
06/11/2024 to 06/11/2024

Kontakt Day FHNW
FHNW Muttenz, Hofackerstrasse 30, 4132 Muttenz
Meet us from 17.00 – 19.00 h
01/04/2025 to 01/04/2025

CPhI North America 2025
Pennsylvania Convention Center, Philadelphia
Booth #317
20/05/2025 to 22/05/2025

Bio Japan 2025
PACIFICO Yokohama, Yokohama, Kanagawa, Japan
@SWISS Pavilion
08/10/2025 to 10/10/2025
Access Our Media Kit
Subscribe to our mailing list for the latest news updates
Join over 4,000 people who already receive news updates from us